FDA Rips Providers For Shoddy Clinical Trial Oversight
The U.S. Food and Drug Administration on Tuesday released highly critical letters related to supervision of clinical trials by two health care providers, dressing down a hospital for allegedly overlooking special...To view the full article, register now.
Already a subscriber? Click here to view full article